The event will discuss data from emerging OX40/OX40L inhibitors, including Inmagene’s IMG-007 - the only clinical-stage non-depleting anti-OX40 mAb. A live question and answer session will follow the ...
Estrogens are known to drive tumor growth in breast cancer cells that carry its receptors, but a new study by Duke Cancer Institute researchers unexpectedly finds that estrogens play a role in fueling ...
He is a significant addition to our team, where in the near term he will assist with development of DPX formulations for our peanut allergy vaccine program with McMaster University ... as well as the ...
New U.S. patent issued covering the identification of a novel biomarker of coronavirus pneumonia (=60% fraction of inspired oxygen (FiO2)) prognostic for potential opaganib efficacy in treating ...